A phase 1 study of AG-013736 (axitinib) in Japanese patients with advanced solid tumors.
Phase of Trial: Phase I
Latest Information Update: 22 May 2012
At a glance
- Drugs Axitinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 22 Sep 2009 Actual end date (August 2009) added as reported by ClinicalTrials.gov.
- 22 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.